A rare variant of carcinoma of the cervix: neuroendocrine tumour

Maya Menon, Sridevi TA, Satish Selvakumar A, Rajeswari RR


Neuroendocrine neoplasm that occurs in the uterine cervix is rare. It accounts for 0.5-1% of all malignant tumours of the uterine cervix. A 55 years old female patient complained of postmenopausal bleeding and history of foul smelling discharge per vagina since 1 month. On examination cervix appeared bulky, both lips indurated, bleeds on touch, both parametrium involved but not up to pelvic wall with bulky uterus. Vagina and per rectal mucosa was free. Clinical diagnosis of carcinoma cervix, stage 2B was made. Cervix biopsy with HPE revealed squamous epithelium of cervix showing neoplastic cells arranged in nests and prominent perivascular pattern, small round cells with minimal cytoplasm and hyperchromatic nucleus, abundant mitosis, cells showed rosette pattern and isolated foci of cell debris and necrosis.  Diagnosis of neuroendocrine tumour of cervix was considered. Immunohistochemistry for cytokeratin, neuron specific enolase, chromogranin and synaptophysin was positive, confirming the final diagnosis of neuroendocrine carcinoma cervix (High grade of small cell type). Recognition of Neuroendocrine carcinoma cervix is important for appropriate therapy & management since these patients have worse clinical outcomes when compared with conventional squamous /adeno carcinoma of cervix. Immunohistochemistry should be supplemented with ultrastructural studies for confirmation and correct categorisation of carcinoma cervix for appropriate management.


Carcinoma cervix, Immunohistochemistry, Neuroendocrine tumour

Full Text:



Gilks CB, Young RH, Gersell DJ, Clement PB. Large cell carcinoma of uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol. 1997;21(8):905-14.

Huang L, Li C, Chen C, Lee C, Chu P. Small cell carcinoma of the uterine cervix: a case report with emphasis on cytopathological finding. Tzu Chi Med J. 2006;18(6):456-61.

Mannion C, Park WS, Man YG, Zhuang Z, Saavedra AJ, Tavassoli FA. Endocrine tumors of the cervix: morphologic assessment expression of human papilloma virus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p. Cancer. 1998;83:1391-400.

Conner MG, Richter H, Moran CA, Hameed A, Saavedra AJ. Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases. Ann Diagn Pathol. 2002;6:345-8.

Savargaonkar PR, Hale RJ, Mutton A, Manning V, Buckley CH. Neuroendocrine differentiation in cervical carcinoma. J Clin Pathol. 1996;49:139-41.

Saavedra AJ, Gersell D, Gilks CB, Henson DE, Lindberg G, Santiago H, et al. Terminology of endocrine tumours of uterine cervix: results of a workshop sponsored by the college of American pathologists and the national cancer institute. Arch Pathol Lab Med. 1997;121(1):34-9.

Bermudez A, Vighi S, Garcia A, Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynaecol Oncol. 2001;82(1):32-9.

Koch CA, Azumi N, Furlong MA, Jha RC, Kehoe TE, Trowbridge CH, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999;84(11):4209-13.

Stockdale AD, Leader M, Philips RH, Henry K. The carcinoid syndrome and multiple hormone secretion associated with a carcinoid tumour of the uterine cervix Case report. Br J Obstet Gynaecol. 1986;93(4):397-401.

Benda JA. Histopathologic prognostic factors in early stage cervical carcinoma. J Natl Cancer Inst Monogr. 1996;(21):27-34.

Ambros RA, Park JS, Shah KV, Kurman RJ. Evaluation of histologic, morphometric and immunohistochemical criteria in the differential diagnosis of small cell carcinoma of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol. 1991;4:586-93.

Hellweg DG, Doeberitz M, Trunk MJ. Malignant tumour, neuroendocrine types. In: Hellweg DG, Doeberitz M, Trunk MJ, eds. Colour Atlas of Histopathology of the Cervix Uteri. 2nd ed. New York: Springer Science & Business Media; 2005: 165-166.

O Hanlan KA, Goldberg GL, Jones JG, Runowicz CD, Ehrlich L, Rodriguez RL. Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature. Gynaecol Oncol. 1991;43:167-72.

Viswanathan AN, Deavers MT, Ihingran A. Small cell neuroendocrine carcinoma of the cervix outcome and patterns of recurrence. Gynaecol Oncol. 2004;93:27-33.

Baum RP, Swietaszczyk C, Prasad V. FDG-PET/CT in lung cancer: an update. Front Radiat Ther Oncol. 2010;42:15-45.

Pecorelli S, Zigliani I, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105:107-8.

Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and factors of small cell carcinoma of the cervix. Obstet Gynaecol. 2008;111:1394.

Zivanovic O, Leitao MM Jr, Park KJ, Zhao H, Diaz JP, Konner J, et al. Small cell neuroendocrine carcinoma of the cervix: analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynaecol Oncol. 2009;112:590-3.